Compare with AstraZeneca PLC


Market capitalization
‪225.50 B‬ EURMega cap
5.85 EUR
‪8.90 B‬ EUR
‪51.12 B‬ EUR
‪1.50 B‬
Beta (1Y)
1.27
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Employees (FY)
‪96.1 K‬
Change (1Y)
‪+1.8 K‬+1.91%
Revenue / Employee (1Y)
‪531.98 K‬ EUR
Net income / Employee (1Y)
‪92.61 K‬ EUR

Company info


CEO
Pascal Soriot
Headquarters
Cambridge
Founded
1913
IPO date
Sep 21, 2007
ISIN
GB0009895292
FIGI
BBG01BPG0G41
Identifiers
ISIN GB0009895292
CFI code
ESVUFR
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateAug 17, 2048
Coupon4.38% (Fixed)
Maturity dateNov 16, 2045
Coupon4.38% (Fixed)
Maturity dateAug 6, 2050
Coupon2.13% (Fixed)
Maturity dateMay 28, 2051
Coupon3.00% (Fixed)
Maturity dateSep 18, 2042
Coupon4.00% (Fixed)
Maturity dateSep 15, 2037
Coupon6.45% (Fixed)
Maturity dateMar 2, 2036
Coupon4.60% (Fixed)
Maturity dateFeb 26, 2034
Coupon5.00% (Fixed)
Maturity dateMay 28, 2031
Coupon2.25% (Fixed)
Maturity dateMar 2, 2033
Coupon4.30% (Fixed)
Maturity dateMar 3, 2033
Coupon4.88% (Fixed)

See all ZEG bonds 

Weight0.52%
Market value‪3.57 B‬
Weight0.72%
Market value‪2.37 B‬
Weight1.01%
Market value‪1.92 B‬
Weight7.32%
Market value‪1.63 B‬
Weight1.18%
Market value‪904.71 M‬
Weight6.87%
Market value‪623.01 M‬
Weight1.48%
Market value‪581.50 M‬
Weight0.57%
Market value‪577.67 M‬

Explore more ETFs 

Frequently asked questions


The current price of ZEG is 150.70 EUR — it has increased by 1.83% in the past 24 hours. Watch AstraZeneca PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSESOF exchange AstraZeneca PLC stocks are traded under the ticker ZEG.
ZEG stock has risen by 1.51% compared to the previous week, the month change is a 1.90% rise, over the last year AstraZeneca PLC has showed a 4.07% increase.
We've gathered analysts' opinions on AstraZeneca PLC future price: according to them, ZEG price has a max estimate of 234.67 EUR and a min estimate of 138.65 EUR. Watch ZEG chart and read a more detailed AstraZeneca PLC stock forecast: see what analysts think of AstraZeneca PLC and suggest that you do with its stocks.
ZEG reached its all-time high on Feb 18, 2026 with the price of 179.50 EUR, and its all-time low was 115.15 EUR and was reached on Apr 11, 2025. View more price dynamics on ZEG chart.
See other stocks reaching their highest and lowest prices.
ZEG stock is 4.11% volatile and has beta coefficient of 1.27. Track AstraZeneca PLC stock price on the chart and check out the list of the most volatile stocks — is AstraZeneca PLC there?
Today AstraZeneca PLC has the market capitalization of ‪225.62 B‬, it has decreased by −1.94% over the last week.
Yes, you can track AstraZeneca PLC financials in yearly and quarterly reports right on TradingView.
AstraZeneca PLC is going to release the next earnings report on Oct 30, 2026. Keep track of upcoming events with our Earnings Calendar.
ZEG earnings for the last quarter are 2.30 EUR per share, whereas the estimation was 2.17 EUR resulting in a 6.21% surprise. The estimated earnings for the next quarter are 2.29 EUR per share. See more details about AstraZeneca PLC earnings.
AstraZeneca PLC revenue for the last quarter amounts to ‪13.47 B‬ EUR, despite the estimated figure of ‪13.52 B‬ EUR. In the next quarter, revenue is expected to reach ‪14.15 B‬ EUR.
ZEG net income for the last quarter is ‪2.17 B‬ EUR, while the quarter before that showed ‪2.62 B‬ EUR of net income which accounts for 0.00% change. Track more AstraZeneca PLC financial stats to get the full picture.
Yes, ZEG dividends are paid semi-annually. The last dividend per share was 0.93 EUR. As of today, Dividend Yield (TTM)% is 0.00%. Tracking AstraZeneca PLC dividends might help you take more informed decisions.
AstraZeneca PLC dividend yield was 1.71% in 2025, and payout ratio reached 47.19%. The year before the numbers were 2.35% and 69.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 16, 2026, the company has ‪96.1 K‬ employees. See our rating of the largest employees — is AstraZeneca PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AstraZeneca PLC EBITDA is ‪17.37 B‬ EUR, and current EBITDA margin is 33.19%. See more stats in AstraZeneca PLC financial statements.
Like other stocks, ZEG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AstraZeneca PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AstraZeneca PLC technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AstraZeneca PLC stock shows the buy signal. See more of AstraZeneca PLC technicals for a more comprehensive analysis.